Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Disentangling molecular alterations from water-content changes in the aging human brain using quantitative MRI.

Filo S, Shtangel O, Salamon N, Kol A, Weisinger B, Shifman S, Mezer AA.

Nat Commun. 2019 Jul 30;10(1):3403. doi: 10.1038/s41467-019-11319-1.

2.

Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma.

Caumanns JJ, van Wijngaarden A, Kol A, Meersma GJ, Jalving M, Bernards R, van der Zee AGJ, Wisman GBA, de Jong S.

Cancer Lett. 2019 Oct 1;461:102-111. doi: 10.1016/j.canlet.2019.07.004. Epub 2019 Jul 15.

3.

MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells.

Stutvoet TS, Kol A, de Vries EG, de Bruyn M, Fehrmann RS, Terwisscha van Scheltinga AG, de Jong S.

J Pathol. 2019 Sep;249(1):52-64. doi: 10.1002/path.5280. Epub 2019 May 21.

4.

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.

Workel HH, Lubbers JM, Arnold R, Prins TM, van der Vlies P, de Lange K, Bosse T, van Gool IC, Eggink FA, Wouters MCA, Komdeur FL, van der Slikke EC, Creutzberg CL, Kol A, Plat A, Glaire M, Church DN, Nijman HW, de Bruyn M.

Cancer Immunol Res. 2019 May;7(5):784-796. doi: 10.1158/2326-6066.CIR-18-0517. Epub 2019 Mar 14.

PMID:
30872264
5.

Concise Review: Canine Diabetes Mellitus as a Translational Model for Innovative Regenerative Medicine Approaches.

Moshref M, Tangey B, Gilor C, Papas KK, Williamson P, Loomba-Albrecht L, Sheehy P, Kol A.

Stem Cells Transl Med. 2019 May;8(5):450-455. doi: 10.1002/sctm.18-0163. Epub 2019 Feb 5. Review.

6.

Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory Enhancement.

Adamsky A, Kol A, Kreisel T, Doron A, Ozeri-Engelhard N, Melcer T, Refaeli R, Horn H, Regev L, Groysman M, London M, Goshen I.

Cell. 2018 Jun 28;174(1):59-71.e14. doi: 10.1016/j.cell.2018.05.002. Epub 2018 May 24.

7.

Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses.

Textor JA, Clark KC, Walker NJ, Aristizobal FA, Kol A, LeJeune SS, Bledsoe A, Davidyan A, Gray SN, Bohannon-Worsley LK, Woolard KD, Borjesson DL.

Stem Cells Transl Med. 2018 Jan;7(1):98-108. doi: 10.1002/sctm.17-0071. Epub 2017 Oct 24.

8.

89Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment.

Pool M, Kol A, de Jong S, de Vries EGE, Lub-de Hooge MN, Terwisscha van Scheltinga AGT.

MAbs. 2017 Nov/Dec;9(8):1370-1378. doi: 10.1080/19420862.2017.1371382. Epub 2017 Sep 5.

9.

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells.

Kol A, Terwisscha van Scheltinga A, Pool M, Gerdes C, de Vries E, de Jong S.

Oncotarget. 2017 Jul 11;8(28):45432-45446. doi: 10.18632/oncotarget.17139.

10.

Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome.

Clark KC, Fierro FA, Ko EM, Walker NJ, Arzi B, Tepper CG, Dahlenburg H, Cicchetto A, Kol A, Marsh L, Murphy WJ, Fazel N, Borjesson DL.

Stem Cell Res Ther. 2017 Mar 20;8(1):69. doi: 10.1186/s13287-017-0528-z.

11.

89Zr-Onartuzumab PET imaging of c-MET receptor dynamics.

Pool M, Terwisscha van Scheltinga AGT, Kol A, Giesen D, de Vries EGE, Lub-de Hooge MN.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1328-1336. doi: 10.1007/s00259-017-3672-x. Epub 2017 Mar 19.

12.

Clinical and Histopathologic Characterization of Canine Chronic Ulcerative Stomatitis.

Anderson JG, Peralta S, Kol A, Kass PH, Murphy B.

Vet Pathol. 2017 May;54(3):511-519. doi: 10.1177/0300985816688754. Epub 2017 Jan 23.

13.

Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.

Owens SD, Kol A, Walker NJ, Borjesson DL.

Stem Cells Int. 2016;2016:5830103. doi: 10.1155/2016/5830103. Epub 2016 Aug 28.

14.

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab.

Pool M, Kol A, Lub-de Hooge MN, Gerdes CA, de Jong S, de Vries EG, Terwisscha van Scheltinga AG.

Oncotarget. 2016 Oct 18;7(42):68111-68121. doi: 10.18632/oncotarget.11827.

15.

Serum levels of innate immunity cytokines are elevated in dogs with metaphyseal osteopathy (hypertrophic osteodytrophy) during active disease and remission.

Safra N, Hitchens PL, Maverakis E, Mitra A, Korff C, Johnson E, Kol A, Bannasch MJ, Pedersen NC, Bannasch DL.

Vet Immunol Immunopathol. 2016 Oct 15;179:32-5. doi: 10.1016/j.vetimm.2016.08.003. Epub 2016 Aug 3.

16.

Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies.

Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ.

Clin Cancer Res. 2016 Sep 1;22(17):4328-40. doi: 10.1158/1078-0432.CCR-15-3026. Epub 2016 Mar 15.

17.

Th17 Pathway As a Target for Multipotent Stromal Cell Therapy in Dogs: Implications for Translational Research.

Kol A, Walker NJ, Nordstrom M, Borjesson DL.

PLoS One. 2016 Feb 12;11(2):e0148568. doi: 10.1371/journal.pone.0148568. eCollection 2016.

18.

Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.

Clark KC, Kol A, Shahbenderian S, Granick JL, Walker NJ, Borjesson DL.

Stem Cell Rev Rep. 2016 Apr;12(2):245-56. doi: 10.1007/s12015-015-9638-0.

19.

Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.

Arzi B, Mills-Ko E, Verstraete FJ, Kol A, Walker NJ, Badgley MR, Fazel N, Murphy WJ, Vapniarsky N, Borjesson DL.

Stem Cells Transl Med. 2016 Jan;5(1):75-86. doi: 10.5966/sctm.2015-0127. Epub 2015 Nov 18.

20.

Companion animals: Translational scientist's new best friends.

Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL.

Sci Transl Med. 2015 Oct 7;7(308):308ps21. doi: 10.1126/scitranslmed.aaa9116. Review.

21.

Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.

Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, Walker NJ, Clark KC, Watson JL, Borjesson DL.

Stem Cell Res Ther. 2015 Apr 15;6:73. doi: 10.1186/s13287-015-0050-0.

22.

Chronic administration of sildenafil improves erectile function in a rat model of chronic renal failure.

Gurbuz N, Kol A, Ipekci T, Ates E, Baykal A, Usta MF.

Asian J Androl. 2015 Sep-Oct;17(5):797-801. doi: 10.4103/1008-682X.146973.

23.

Increased serum concentrations of adiponectin in canine hypothyroidism.

Mazaki-Tovi M, Abood SK, Kol A, Farkas A, Schenck PA.

Vet J. 2015 Feb;203(2):253-5. doi: 10.1016/j.tvjl.2014.12.007. Epub 2014 Dec 12.

PMID:
25555336
24.

Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development.

Arzi B, Kol A, Murphy B, Walker NJ, Wood JA, Clark K, Verstraete FJ, Borjesson DL.

Stem Cells Dev. 2015 Apr 1;24(7):814-23. doi: 10.1089/scd.2014.0317. Epub 2014 Dec 31.

25.

Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.

Kol A, Foutouhi S, Walker NJ, Kong NT, Weimer BC, Borjesson DL.

Stem Cells Dev. 2014 Aug 15;23(16):1831-43. doi: 10.1089/scd.2014.0128. Epub 2014 Jun 26.

26.

HER3, serious partner in crime: therapeutic approaches and potential biomarkers for effect of HER3-targeting.

Kol A, Terwisscha van Scheltinga AG, Timmer-Bosscha H, Lamberts LE, Bensch F, de Vries EG, Schröder CP.

Pharmacol Ther. 2014 Jul;143(1):1-11. doi: 10.1016/j.pharmthera.2014.01.005. Epub 2014 Feb 7. Review.

PMID:
24513440
27.

Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells.

Hoffmann RF, Zarrintan S, Brandenburg SM, Kol A, de Bruin HG, Jafari S, Dijk F, Kalicharan D, Kelders M, Gosker HR, Ten Hacken NH, van der Want JJ, van Oosterhout AJ, Heijink IH.

Respir Res. 2013 Oct 2;14:97. doi: 10.1186/1465-9921-14-97.

28.

Characterization of thrombelastography over time in dogs with hyperadrenocorticism.

Kol A, Nelson RW, Gosselin RC, Borjesson DL.

Vet J. 2013 Sep;197(3):675-81. doi: 10.1016/j.tvjl.2013.05.047. Epub 2013 Jul 6.

PMID:
23838206
29.

Serial haemostatic monitoring of dogs with multicentric lymphoma.

Kol A, Marks SL, Skorupski KA, Kass PH, Guerrero T, Gosselin RC, Borjesson DL.

Vet Comp Oncol. 2015 Sep;13(3):255-66. doi: 10.1111/vco.12041. Epub 2013 May 25.

PMID:
23710569
30.

B-cell lymphoma with plasmacytoid differentiation, atypical cytoplasmic inclusions, and secondary leukemia in a dog.

Kol A, Christopher MM, Skorupski KA, Tokarz D, Vernau W.

Vet Clin Pathol. 2013 Mar;42(1):40-6. doi: 10.1111/vcp.12003. Epub 2012 Dec 3.

PMID:
23205858
31.

Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression.

Kol A, Walker NJ, Galuppo LD, Clark KC, Buerchler S, Bernanke A, Borjesson DL.

Equine Vet J. 2013 Mar;45(2):193-8. doi: 10.1111/j.2042-3306.2012.00600.x. Epub 2012 Jul 11.

PMID:
22780195
32.

Diagnosis of testicular torsion by measuring attenuation of dual wavelengths in transmission geometry across the testis: an experimental study in a rat model.

Canpolat M, Yucel S, Sircan-Kucuksayan A, Kol A, Kazanci HO, Denkceken T.

Urology. 2012 Apr;79(4):966.e9-12. doi: 10.1016/j.urology.2011.12.005. Epub 2012 Feb 7.

PMID:
22321960
33.

[The effect of flunarizine pretreatment on postoperative morphine consumption].

Kol A, Güleç S, Ceyhan D, Bilir A.

Agri. 2011 Jul;23(3):93-9. doi: 10.5505/agri.2011.52207. Turkish.

34.

The interpretation of thromboelastography tracings: many (more) rivers to cross.

Kol A.

Vet J. 2012 Mar;191(3):275-6. doi: 10.1016/j.tvjl.2011.06.034. Epub 2011 Jul 29. No abstract available.

PMID:
21802964
35.

Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis.

Yucel S, Kol A, Guntekin E, Baykara M.

Urology. 2011 Mar;77(3):721-4. doi: 10.1016/j.urology.2010.06.061. Epub 2011 Jan 7.

PMID:
21215431
36.

Initial pre-scrotal approach for palpable cryptorchid testis: results during a 3-year period.

Yucel S, Celik O, Kol A, Baykara M, Guntekin E.

J Urol. 2011 Feb;185(2):669-72. doi: 10.1016/j.juro.2010.09.117. Epub 2010 Dec 18.

PMID:
21172700
37.

Experience on semirigid ureteroscopy and pneumatic lithotripsy in children at a single center.

Yucel S, Akin Y, Kol A, Danisman A, Guntekin E.

World J Urol. 2011 Dec;29(6):719-23. doi: 10.1007/s00345-010-0599-2. Epub 2010 Oct 7.

PMID:
21079969
38.

Application of thrombelastography/thromboelastometry to veterinary medicine.

Kol A, Borjesson DL.

Vet Clin Pathol. 2010 Dec;39(4):405-16. doi: 10.1111/j.1939-165X.2010.00263.x. Epub 2010 Oct 22. Review.

PMID:
20969608
39.

Noncompacted ventricular myocardium: characterization by intracardiac echo.

Ficili S, Pandozi C, Galeazzi M, Kol A, Russo M, Lavalle C, Dottori S, Santini M.

J Cardiovasc Med (Hagerstown). 2011 Apr;12(4):294-6. doi: 10.2459/JCM.0b013e32833e5892.

PMID:
20856134
40.

Eumycetoma caused by Madurella mycetomatis in a mare.

Elad D, Blum S, Kol A, Ederi N, David D.

Med Mycol. 2010 Jun;48(4):639-42. doi: 10.3109/13693780903393905.

PMID:
19886776
41.

Increased serum leptin and insulin concentrations in canine hypothyroidism.

Mazaki-Tovi M, Feuermann Y, Segev G, Klement E, Yas-Natan E, Farkas A, Kol A, Shamay A.

Vet J. 2010 Jan;183(1):109-114. doi: 10.1016/j.tvjl.2008.08.017. Epub 2008 Oct 2.

PMID:
18835199
42.

A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.

Antonini L, Colivicchi F, Pasceri V, Greco S, Varveri A, Turani L, Kol A, Santini M.

Pacing Clin Electrophysiol. 2008 Sep;31(9):1089-94. doi: 10.1111/j.1540-8159.2008.01146.x.

PMID:
18834457
43.

Ambulatory blood pressure monitoring early after acute myocardial infarction: development of a new prognostic index.

Antonini L, Pasceri V, Greco S, Colivicchi F, Malfatti S, Pede S, Guido V, Kol A, Santini M.

Blood Press Monit. 2007 Apr;12(2):69-74.

PMID:
17353648
44.

Stress cardiomyopathy with apical thrombosis promptly diagnosed with cardiovascular MRI.

Camastra GS, Cacciotti L, Kol A, Ansalone G.

Cardiology. 2006;105(2):108-9. Epub 2005 Dec 12. No abstract available.

PMID:
16352872
45.

Infectious agents and atherosclerosis: current perspectives and unsolved issues.

Kol A, Santini M.

Ital Heart J. 2004 May;5(5):350-7. Review.

PMID:
15185898
46.
47.
48.

Molecular mediators of arterial inflammation: a role for microbial products?

Kol A, Libby P.

Am Heart J. 1999 Nov;138(5 Pt 2):S450-2. Review. No abstract available.

PMID:
10539846
49.

Comparison of response to serotonin of radial artery grafts and internal mammary grafts to native coronary arteries and the effect of diltiazem.

Sperti G, Manasse E, Kol A, Canosa C, Grego S, Milici C, Schiavello R, Possati GF, Crea F, Maseri A.

Am J Cardiol. 1999 Feb 15;83(4):592-6, A8.

PMID:
10073868
50.

Supplemental Content

Support Center